Analysts Point To Encompass Health Corp (NYSE: EHC) Growth In The Future

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Recently, Yahoo Finance discussed the stock, revealing that Encompass Health announces preliminary plans to build a 50-bed inpatient rehabilitation hospital in San Antonio.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NYSE listed company, EHC falls under the Healthcare sector while operating within the Medical Care Facilities industry segment. The current market capitalization of Encompass Health Corp is $8.35B. A total of 0.87 million shares were traded on the day, compared to an average of 656.32K shares.

In the most recent transaction, COLTHARP DOUGLAS E sold 11,215 shares of EHC for 63.39 per share on Nov 13 ’23. After the transaction, the EVP & Chief Financial Officer now owns 116,293 company shares. In a previous transaction on Aug 17 ’23, Charbonneau Elissa Joy sold 8,294 shares at 69.58 per share. EHC shares that Chief Medical Officer owns now total 23,081.

Among the insiders who sold shares, Tarr Mark J disposed of 25,330 shares on Aug 16 ’23 at a per-share price of $71.06. This resulted in the President & CEO holding 497,405 shares of EHC after the transaction.

Dividend

Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Encompass Health Corp pays an annual dividend of $0.60, resulting in a dividend yield of 0.72%, and it has a price to earnings (P/E) ratio of 23.97. EHC’s most recent ex-dividend date was 3/28/2024 when it declared a $0.15 quarterly dividend that was paid in cash on 4/15/2024. Previously, the company paid the dividend on 1/16/2024 with an ex-dividend date of 12/29/2023. The EHC stock dividend was $0.15 per share in cash.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EHC has a high of $83.73 and a low of $57.55.

As of this writing, EHC has an earnings estimate of $0.93 per share for the current quarter. EPS was calculated based on a consensus of 11 estimates, with a high estimate of $1.01 per share and a lower estimate of $0.88. The company reported an EPS of $0.86 in the last quarter, which was 11.70% higher than expectations of $0.77.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EHC’s latest balance sheet shows that the firm has $49.40M in Cash & Short Term Investments as of fiscal 2021. There were $3.48B in debt and $748.80M in liabilities at the time. Its Book Value Per Share was $16.43, while its Total Shareholder’s Equity was $2.40B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EHC is Buy with a score of 4.90.

Most Popular

Related Posts